More on EPRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/7/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Eupraxia Pharmaceuticals (NQ:EPRX)
Delayed: 6.04 +0.01 (0.17%)
Prev. Close $6.03  
Open$6.06 
52 Wk High$ 
52 Wk Low$ 
Day High$6.20 
Day Low$5.96 
P/E N/A  
EPS$ 
Volume141,123 

Friends, Peers and Foes (?): ABB, EPF, EPFCF, FLT, HCU (more...)

May 29, 2026 02:18 PM Form 6-K EUPRAXIA PHARMACEUTICALS For: Jun 18
May 29, 2026 02:10 PM Form 6-K EUPRAXIA PHARMACEUTICALS For: May 28
May 28, 2026 05:11 PM Form 6-K EUPRAXIA PHARMACEUTICALS For: May 28
May 28, 2026 08:00 AM Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 20, 2026 04:06 PM Stifel Starts Eupraxia Pharmaceuticals (EPRX) at Buy
May 12, 2026 07:04 PM Form SCHEDULE 13G/A EUPRAXIA PHARMACEUTICALS Filed by: MANCHESTER MANAGEMENT CO LLC
May 12, 2026 05:07 PM Form 6-K EUPRAXIA PHARMACEUTICALS For: May 12
May 12, 2026 05:00 PM Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results
May 6, 2026 07:00 AM Form 6-K EUPRAXIA PHARMACEUTICALS For: May 06
May 6, 2026 07:00 AM Eupraxia Pharmaceuticals reports tissue improvements in EoE trial
View All Articles

Entities mentioned with EPRX

View All Entities